Predictors of liver histological changes and a sustained virological response to peginterferon among chronic hepatitis B e antigen-positive patients with normal or minimally elevated alanine aminotransferase levels-Reference-Cited by-同舟云学术

Predictors of liver histological changes and a sustained virological response to peginterferon among chronic hepatitis B e antigen-positive patients with normal or minimally elevated alanine aminotransferase levels

Published:2017-02-16 Issue:7 Volume:24 Page:573-579
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Chen J.¹^ORCID,Xu C. R.²,Xi M.¹,Hu W. W.¹,Tang Z. H.¹,Zang G. Q.¹

Affiliation:

1. Department of Infectious Disease; The Sixth People's Hospital affiliated with Shanghai Jiao Tong University; Shanghai China

2. Department of Infectious Disease; Southeast Hospital affiliated with Xiamen University; Zhangzhou China

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12679/fullpdf

Reference21 articles.

1. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers;Yu;Am J Epidemiol,1997

2. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy;Liaw;Antivir Ther,2006

3. Reasons to consider earlier treatment of chronic HBV infections;Zoulim;Gut,2012

4. Histologic changes in liver tissue from patients with chronic hepatitis B and minimal increases in levels of alanine aminotransferase: a meta-analysis and systematic review;Nguyen;Clin Gastroenterol Hepatol,2014

5. Significant fibrosis is not rare in Chinese chronic hepatitis B patients with persistent normal ALT;Liao;PLoS One,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naif Kronik Hepatit B Tedavisinde Tenofovir Alafenamid: Tek Merkezli Retrospektif Çalışma;ANKEM Dergisi;2024-04-30

2. Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?;Current Hepatology Reports;2024-02-12

3. Effective Analysis of Antiviral Treatment in Patients with HBeAg-Seropositive Chronic Hepatitis B with ALT < 2 Upper Limits of Normal: A Multi-center Retrospective Cohort Study;Infectious Diseases and Therapy;2023-01-12

4. Simplifying Treatment Criteria in Chronic Hepatitis B: Reducing Barriers to Elimination;Clinical Infectious Diseases;2022-05-20

5. Should Treatment Indications for Chronic Hepatitis B Be Expanded?;Clinical Gastroenterology and Hepatology;2021-10